These data suggest that breast cancers with low ER positivity and those with ER negativity have similar molecular features and clinical prognoses, and the threshold of 1% stained cancer cells to define ER-positive status cannot accurately reflect the biological and clinical characteristics of tumors. This evidence concerns the gene ESR1 and breast carcinoma.